Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological Slides.


Journal

Hepatology (Baltimore, Md.)
ISSN: 1527-3350
Titre abrégé: Hepatology
Pays: United States
ID NLM: 8302946

Informations de publication

Date de publication:
12 2020
Historique:
received: 29 10 2019
revised: 23 12 2019
accepted: 09 02 2020
pubmed: 29 2 2020
medline: 5 5 2021
entrez: 29 2 2020
Statut: ppublish

Résumé

Standardized and robust risk-stratification systems for patients with hepatocellular carcinoma (HCC) are required to improve therapeutic strategies and investigate the benefits of adjuvant systemic therapies after curative resection/ablation. In this study, we used two deep-learning algorithms based on whole-slide digitized histological slides (whole-slide imaging; WSI) to build models for predicting survival of patients with HCC treated by surgical resection. Two independent series were investigated: a discovery set (Henri Mondor Hospital, n = 194) used to develop our algorithms and an independent validation set (The Cancer Genome Atlas [TCGA], n = 328). WSIs were first divided into small squares ("tiles"), and features were extracted with a pretrained convolutional neural network (preprocessing step). The first deep-learning-based algorithm ("SCHMOWDER") uses an attention mechanism on tumoral areas annotated by a pathologist whereas the second ("CHOWDER") does not require human expertise. In the discovery set, c-indices for survival prediction of SCHMOWDER and CHOWDER reached 0.78 and 0.75, respectively. Both models outperformed a composite score incorporating all baseline variables associated with survival. Prognostic value of the models was further validated in the TCGA data set, and, as observed in the discovery series, both models had a higher discriminatory power than a score combining all baseline variables associated with survival. Pathological review showed that the tumoral areas most predictive of poor survival were characterized by vascular spaces, the macrotrabecular architectural pattern, and a lack of immune infiltration. This study shows that artificial intelligence can help refine the prediction of HCC prognosis. It highlights the importance of pathologist/machine interactions for the construction of deep-learning algorithms that benefit from expert knowledge and allow a biological understanding of their output.

Sections du résumé

BACKGROUND AND AIMS
Standardized and robust risk-stratification systems for patients with hepatocellular carcinoma (HCC) are required to improve therapeutic strategies and investigate the benefits of adjuvant systemic therapies after curative resection/ablation.
APPROACH AND RESULTS
In this study, we used two deep-learning algorithms based on whole-slide digitized histological slides (whole-slide imaging; WSI) to build models for predicting survival of patients with HCC treated by surgical resection. Two independent series were investigated: a discovery set (Henri Mondor Hospital, n = 194) used to develop our algorithms and an independent validation set (The Cancer Genome Atlas [TCGA], n = 328). WSIs were first divided into small squares ("tiles"), and features were extracted with a pretrained convolutional neural network (preprocessing step). The first deep-learning-based algorithm ("SCHMOWDER") uses an attention mechanism on tumoral areas annotated by a pathologist whereas the second ("CHOWDER") does not require human expertise. In the discovery set, c-indices for survival prediction of SCHMOWDER and CHOWDER reached 0.78 and 0.75, respectively. Both models outperformed a composite score incorporating all baseline variables associated with survival. Prognostic value of the models was further validated in the TCGA data set, and, as observed in the discovery series, both models had a higher discriminatory power than a score combining all baseline variables associated with survival. Pathological review showed that the tumoral areas most predictive of poor survival were characterized by vascular spaces, the macrotrabecular architectural pattern, and a lack of immune infiltration.
CONCLUSIONS
This study shows that artificial intelligence can help refine the prediction of HCC prognosis. It highlights the importance of pathologist/machine interactions for the construction of deep-learning algorithms that benefit from expert knowledge and allow a biological understanding of their output.

Identifiants

pubmed: 32108950
doi: 10.1002/hep.31207
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2000-2013

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2020 by the American Association for the Study of Liver Diseases.

Références

Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, et al. Hepatocellular carcinoma. Nat Rev Dis Primers 2016;2:16018.
Goldblum JR, Lamps LW, McKenney JK, Myers JL, Ackerman LV, Rosai J. Rosai and Ackerman’s Surgical Pathology, 11th ed. Philadelphia, PA: Elsevier; 2018:2 volumes (xiv, 2142 pages).
Niazi MKK, Parwani AV, Gurcan MN. Digital pathology and artificial intelligence. Lancet Oncol 2019;20:e253-e261.
Ehteshami Bejnordi B, Veta M, Johannes van Diest P, van Ginneken B, Karssemeijer N, Litjens G, et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast Cancer. JAMA 2017;318:2199-2210.
Coudray N, Ocampo PS, Sakellaropoulos T, Narula N, Snuderl M, Fenyo D, et al. Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. Nat Med 2018;24:1559-1567.
Yu KH, Zhang C, Berry GJ, Altman RB, Re C, Rubin DL, et al. Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features. Nat Commun 2016;7:12474.
Mobadersany P, Yousefi S, Amgad M, Gutman DA, Barnholtz-Sloan JS, Velazquez Vega JE, et al. Predicting cancer outcomes from histology and genomics using convolutional networks. Proc Natl Acad Sci U S A 2018;115:E2970-E2979.
Kather JN, Krisam J, Charoentong P, Luedde T, Herpel E, Weis CA, et al. Predicting survival from colorectal cancer histology slides using deep learning: a retrospective multicenter study. PLoS Med 2019;16:e1002730.
Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012;2:401-404.
Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013;6:pl1.
Cancer Genome Atlas Research Network. Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell 2017;169:1327-1341.e23.
Davidson-Pilon C, Kalderstam J, Zivich P, Kuhn B, Fiore-Gartland A, et al. CamDavidsonPilon/lifelines: v0.22.9 (Version v0.22.9). Zenodo. 2019 Oct 30. http://doi.org/10.5281/zenodo.3523175.
Davidson-Pilon C, Kalderstam J, Zivich P, Kuhn B, Fiore-Gartland A, Abdeali JK. CamDavidsonPilon/lifelines: v0.22.9 (Version v0.22.9). Zenodo. 2019 Oct 30. http://doi.org/10.5281/zenodo.3523175.
He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. arXiv 2015;arXiv:1512.03385 [cs.CV].
Zucman-Rossi J, Villanueva A, Nault JC, Llovet JM. Genetic landscape and biomarkers of hepatocellular carcinoma. Gastroenterology 2015;149:1226-1239.e4.
Price WN. Big data and black-box medical algorithms. Sci Transl Med 2018;10:eaao5333.
Calderaro J, Couchy G, Imbeaud S, Amaddeo G, Letouze E, Blanc JF, et al. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification. J Hepatol 2017;67;727-738.
Ziol M, Pote N, Amaddeo G, Laurent A, Nault JC, Oberti F, et al. Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance. Hepatology 2018;68:103-112.
Fang JH, Zhou HC, Zhang C, Shang LR, Zhang L, Xu J, et al. A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner. Hepatology 2015;62:452-465.
Renne SL, Woo HY, Allegra S, Rudini N, Yano H, Donadon M, et al. Vessels encapsulating tumor clusters (VETC) is a powerful predictor of aggressive hepatocellular carcinoma. Hepatology 2020;71:183-195.
Calderaro J, Ziol M, Paradis V, Zucman-Rossi J. Molecular and histological correlations in liver cancer. J Hepatol 2019;71:616-630.
Villa E, Critelli R, Lei B, Marzocchi G, Camma C, Giannelli G, et al. Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study. Gut 2016;65:861-869.
MacSween RNM, Burt AD, Portmann B, Ferrell LD. MacSween’s Pathology of the Liver, 6th ed. Edinburgh, UK: Churchill Livingstone; 2011:770-798.

Auteurs

Charlie Saillard (C)

Owkin Lab, Owkin, Paris, France.

Benoit Schmauch (B)

Owkin Lab, Owkin, Paris, France.

Oumeima Laifa (O)

Owkin Lab, Owkin, Paris, France.

Matahi Moarii (M)

Owkin Lab, Owkin, Paris, France.

Sylvain Toldo (S)

Owkin Lab, Owkin, Paris, France.

Mikhail Zaslavskiy (M)

Owkin Lab, Owkin, Paris, France.

Elodie Pronier (E)

Owkin Lab, Owkin, Paris, France.

Alexis Laurent (A)

Assistance Publique-Hôpitaux de Paris, Department of Hepatobiliary and Digestive Surgery, Henri Mondor Hospital, Créteil, France.
Paris Est Créteil University, UPEC, Créteil, France.

Giuliana Amaddeo (G)

Paris Est Créteil University, UPEC, Créteil, France.
INSERM U955, Team "Pathophysiology and Therapy of Chronic Viral Hepatitis and Related Cancers", Créteil, France.
Assistance Publique-Hôpitaux de Paris, Department of Hepatology, Henri Mondor Hospital, Créteil, France.

Hélène Regnault (H)

Assistance Publique-Hôpitaux de Paris, Department of Hepatology, Henri Mondor Hospital, Créteil, France.

Daniele Sommacale (D)

Assistance Publique-Hôpitaux de Paris, Department of Hepatobiliary and Digestive Surgery, Henri Mondor Hospital, Créteil, France.
Paris Est Créteil University, UPEC, Créteil, France.
INSERM U955, Team "Pathophysiology and Therapy of Chronic Viral Hepatitis and Related Cancers", Créteil, France.

Marianne Ziol (M)

Assistance Publique-Hôpitaux de Paris, Department of Pathology, Jean Verdier Hospital, Bondy, France.
Functional Genomics of Solid Tumors, INSERM-1162, Paris 13 University, Paris, France.

Jean-Michel Pawlotsky (JM)

Paris Est Créteil University, UPEC, Créteil, France.
INSERM U955, Team "Pathophysiology and Therapy of Chronic Viral Hepatitis and Related Cancers", Créteil, France.
National Reference Center for Viral Hepatitis B, C and Delta, Department of Virology, Henri Mondor Hospital, Créteil, France.

Sébastien Mulé (S)

Paris Est Créteil University, UPEC, Créteil, France.
INSERM U955, Team "Pathophysiology and Therapy of Chronic Viral Hepatitis and Related Cancers", Créteil, France.
Assistance Publique-Hôpitaux de Paris, Department of Medical Imaging, Henri Mondor Hospital, Créteil, France.

Alain Luciani (A)

Paris Est Créteil University, UPEC, Créteil, France.
INSERM U955, Team "Pathophysiology and Therapy of Chronic Viral Hepatitis and Related Cancers", Créteil, France.
Assistance Publique-Hôpitaux de Paris, Department of Medical Imaging, Henri Mondor Hospital, Créteil, France.

Gilles Wainrib (G)

Owkin Lab, Owkin, Paris, France.

Thomas Clozel (T)

Owkin Lab, Owkin, Paris, France.

Pierre Courtiol (P)

Owkin Lab, Owkin, Paris, France.

Julien Calderaro (J)

Paris Est Créteil University, UPEC, Créteil, France.
INSERM U955, Team "Pathophysiology and Therapy of Chronic Viral Hepatitis and Related Cancers", Créteil, France.
Assistance Publique-Hôpitaux de Paris, Department of Pathology, Henri Mondor Hospital, Créteil, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH